Teamit Research S.l.

Where the EU money came from

Funding by EU programme. Amounts are Teamit Research S.l.'s own share of each project, not the project's full budget.

Projects

14 EU-funded projects, newest first. Each links to the official record.

• EPICA-DIPGPartner

  European Pediatric Immunotherapy Trial with Combinatory ATMPs for DIPG

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €291ktheir share
• FORTIFYPartner

  FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

  Horizon Europe · 2026–2029 · Project on CORDIS ↗

  €581ktheir share
• RealiseDPartner

  Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

  Horizon Europe · 2025–2029 · Project on CORDIS ↗

  €611ktheir share
• UMBRELLAPartner

  Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome Prediction

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €684ktheir share
• ERDERAPartner

  EUROPEAN RARE DISEASES RESEARCH ALLIANCE

  Horizon Europe · 2024–2031 · Project on CORDIS ↗

  €747ktheir share
• WIDEnzymesPartner

  Widening Synergies for Novel Enzymes Development

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €211ktheir share
• FIBROTARGETPartner

  Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €582ktheir share
• REMEDi4ALLPartner

  BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL

  Horizon Europe · 2022–2027 · Project on CORDIS ↗

  €1.8Mtheir share
• PROMISEPartner

  Preparing for RSV Immunisation and Surveillance in Europe

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  €587ktheir share
• H2OPartner

  H2O Health Outcomes Observatory

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €666ktheir share
• PREMIERPartner

  Prioritisation and Risk Evaluation of Medicines in the EnviRonment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €327ktheir share
• EU-PEARLPartner

  EU Patient- cEntric clinicAl tRial pLatform

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  €985ktheir share
• PARADIGMPartner

  Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

  Horizon 2020 · 2018–2020 · Project on CORDIS ↗

  €74ktheir share
• RESCEUPartner

  REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €480ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Janssen Pharmaceutica NVBelgium · 7 shared projects
• Katholieke Universiteit LeuvenBelgium · 6 shared projects
• Astrazeneca ABSweden · 6 shared projects
• Novartis Pharma AGSwitzerland · 6 shared projects
• Pfizer LimitedUnited Kingdom · 6 shared projects
• Fundacio Hospital Universitari Vall D'Hebron - Institut de RecercaSpain · 5 shared projects
• Eatris EricNetherlands · 5 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 5 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 5 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 4 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 4 shared projects
• Charite - Universitaetsmedizin BerlinGermany · 4 shared projects
• Fundacio Privada Per A la Recerca i la Docencia Sant Joan de DeuSpain · 4 shared projects
• Eurordis - Rare Diseases EuropeFrance · 4 shared projects
• Istituto Ortopedico RizzoliItaly · 4 shared projects
• Bayer AktiengesellschaftGermany · 4 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• artificial intelligence
• asthma
• data processing
• data protection
• drug discovery
• ecosystems
• governance
• immunisation
• immunotherapy
• inflammatory bowel disease
• modeling of diseases spread
• personalized medicine
• pharmaceutical drugs
• physiotherapy